Final-Program-ATS-2023-AP.vp

TUESDAY • MAY 23

217

10:10 Data from Wearables as Trial Endpoints K. A. M. Johannson, MD, MPH, ATSF, Calgary, Canada This session and the International Conference are supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. All CME sessions have been planned and implemented in accordance with the Accreditation Criteria of the Accreditation Council for Continuing Medical Education (ACCME®) and are free of the control of ineligible companies (formerly commercial interests).

9:23 Sarcoidosis

M. Sharp, MD, MHS, Baltimore, MD

9:45 Sepsis

S. Bhavani, MD, Atlanta, GA

10:08 Sleep

C. Goldstein, MD, MS, Ann Arbor, MI

BEHAVIORAL • CLINICAL CLINICAL TOPICS IN PULMONARY MEDICINE CME Credits Available: 1.5

CLINICAL CLINICAL TOPICS IN PULMONARY MEDICINE CME Credits Available: 1.5

C2 ENDPOINTS FOR THERAPEUTIC TRIALS IN ILD Assemblies on Clinical Problems; Behavioral Science and Health Services Research 9:00 AM - 10:30 AM Walter E Washington Convention Center Ballroom A (Level 3) Target Audience Providers of lung health; those with clinical and/or research responsibilities; those designing or conducting trials of therapies for patients with ILD; approval agency representatives; pharmaceutical company representatives Objectives At the conclusion of this session, the participant will be able to: • more fully appreciate the need for patient-centric outcomes in trials of therapies for patients with ILD. • consider the use of specific, supplemental oxygen-related outcomes in their studies and trials. • implement patient-centric outcomes that assess how patients with ILD feel and function in their daily lives. Identifying endpoints that meet requirements for patient centricity, applicability given the known or likely mechanisms of the therapeutic intervention and achievability within the constraints of therapeutic trials is key to the design of therapeutic trials for patients with ILD. Chairing: J. Swigris, DO, MS, Denver, CO M. Kalluri, MD, Edmonton, Canada 9:00 Introduction J.J. Swigris, DO, MS, Denver, CO M. Kalluri, MD, Edmonton, Canada 9:10 Patient reported outcomes as endpoints in trial J .J. Swigris, DO, MS, Denver, CO 9:30 Supplemental Oxygen Needs as a Trial Endpoint K.I. Aronson, MD, MSci, New York, NY 9:50 Improving Home Spirometry to Make It a Viable Trial Endpoint A.O. Adegunsoye, MD, MS, Chicago, IL

C3

PEDIATRIC CLINICAL CHEST ROUNDS

Assembly on Pediatrics 9:00 AM - 10:30 AM Walter E. Washington Convention Center Ballroom C (Level 3) Target Audience Pediatric pulmonary clinicians and trainees (including students, physicians, advanced practice providers, nurses, therapists) interested in the diagnosis and management of challenging cases Objectives At the conclusion of this session, the participant will be able to: • generate a broad differential diagnosis for challenging cases in pediatric pulmonary medicine; • apply current diagnostic testing to the management of challenging cases in pediatric pulmonary medicine; • discuss state of the art management of challenging pediatric pulmonary cases Pediatric Clinical Chest Rounds is an annual symposium that focuses on the diagnosis and management of 4 challenging cases selected from case reports submitted to the Pediatric Assembly. Each case is presented by a trainee (typically Ped Pulm fellow) and a discussion of the main points of the case follows (typically an expert in the field). Chairing: T.J. Moraes, MD, PhD, BSc, Toronto, Canada S.C. Sadreameli, MD, MHS, Baltimore, MD C.E. Loughlin, MD, Chapel Hill, NC 9:00 Bar None: The Oddest Case of Desaturations in a Term Infant J. Lee, MD, St. Petersburg FL 9:12 Expert Discussant J. Piccione, MS, DO, ATSF, Philadelphia, PA 9:22 Recurrent Respiratory Failure in a Patient With Sickle Cell Disease M. Alsanjalawi, MD, Gainesville, FL 9:34 Expert Discussant F. Ogunlesi, MBBS, Washington, D.C.

ATS 2023 • Washington, DC